MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

News   Aug 06, 2015

 
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program
 
 
 

RELATED ARTICLES

Trispecific Antibodies Protect Against HIV

News

A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived.

READ MORE

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

News

ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE